Jeremy G Chadwick

Chief Operating Officer

Jeremy G Chadwick (Chief Operating Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $9.0M of KYMR (114,777 sh across 5 lots, as filed), executed Mar 23.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$14.9M

shares × price, as filed

Last traded

May 27

Filed May 27

Median ADV $102.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $14.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

KYMR

Kymera Therapeutics, Inc. KYMR · 0 buys · 6 sells 6 filings

Recent filings

KYMRSALE Kymera Therapeutics, Inc. View filing → $1.3M
15,709 sh across 4 lots
Exec May 26
Filed May 27 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $590K
6,551 sh across 2 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $1.8M
21,140 sh across 2 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $9.0M
114,777 sh across 5 lots
Exec Mar 23
Filed Mar 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $2.1M
25,758 sh across 3 lots
Exec Mar 11
Filed Mar 11 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $172K
2,017 sh × $85.04
Exec Mar 4
Filed Mar 4 · 5:30 PM ET